First Affirmative Financial Network’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $540K | Buy |
1,114
+125
| +13% | +$60.6K | 0.33% | 84 |
|
|
2024
Q4 | $398K | Buy |
989
+19
| +2% | +$7.65K | 0.23% | 119 |
|
|
2024
Q3 | $451K | Buy |
970
+17
| +2% | +$7.91K | 0.25% | 113 |
|
|
2024
Q2 | $447K | Buy |
953
+10
| +1% | +$4.69K | 0.31% | 93 |
|
|
2024
Q1 | $394K | Sell |
943
-1
| -0.1% | -$418 | 0.29% | 106 |
|
|
2023
Q4 | $384K | Buy |
944
+208
| +28% | +$84.6K | 0.31% | 101 |
|
|
2023
Q3 | $256K | Buy |
736
+132
| +22% | +$45.9K | 0.25% | 130 |
|
|
2023
Q2 | $212K | Buy |
+604
| New | +$212K | 0.21% | 159 |
|